Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2009-12-14
2011-12-06
Young, Shawquia (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
08071786
ABSTRACT:
Novel indole compounds are disclosed. Also disclosed are methods for using the compounds to treat human and animal disease, pharmaceutical compositions of the compounds, and kits including the compounds.
REFERENCES:
patent: 3075992 (1963-01-01), Hofmann et al.
patent: 2009/0318527 (2009-12-01), Sard et al.
patent: 9005721 (1990-05-01), None
patent: 0012482 (2000-03-01), None
International Search Report from corresponding international patent application No. PCT/US2005/034413, dated May 8, 2009.
Blair et al., “Effect of Ring Fluorination on the Pharmacology of Hallucinogenic Tryptamines.” Journal of Medicinal Chemistry (2000) p. 4701-4710 August.
Cerletti et al., Advances in Pharmacology (New York) (1968), 6 (Pt. B), 233-46.
Vippagunta et al., Advanced Drug Delivery Reviews 48 (2001) pp. 3-26.
Audia et al., “Potent, Selective Tetrahydro-b-carboline Antagonists of the Serotonin 2B (5HT 2B) Contractile Receptor in the Rat Stomach Fundus,” J. Med. Chem. (1996), vol. 39, pp. 2773-2780.
Bickerdike et al.,“5-HT2C Receptor Modulation and the Treatment of Obesity,” Diabetes Obes. Metab. 1999, vol. 1, pp. 207-214.
Blakeslee, “Scientists Test Hallucinogens for Mental IIIs,” New York Times, Mar. 31 2001, 4 pages.
Bös et al., “Novel Agonists of 5-HT2C Receptors. Synthesis and Biological Evaluation of Substituted 2-(Indo1-1-yl)-1-methylethylamines and 2-(Indeno[1,2-b]pyrrol-1-yl)-1-methylethylamines. Improved Therapeutics for Obsessive Compulsive Disorder,” J. Med. Chem. 1997, 40, 2762-2769.
Brodey et al., abstract of “An electrographic study of psilocin and 4-methyl-a'-methyl-tryptamine,” J. Pharm. & Exp. Ther. (1963), vol. 140, pp. 8-18.
Cliffe et al., “Approaches to 5-HT2C Receptor Agonists: Activity of Saturated Cycloalkyl-fused [b]indole and [b] indole isotryptamines,” Excellence in Neuroscience and CNS Medicine, 224th ACS National Meeting, Aug. 18-22, 2002, Boston (6 pages).
Delgado et al., “Hallucinogens, Serotonin, and Obsessive-Compulsive Disorder,” J. Psychoactive Drugs (Oct.-Dec. 1998), vol. 30(4), pp. 359-366.
Fitzgerald et al., “5-HT2C Receptor Modulators; Progress in Development of New CNS Medicines,” Annual Reports in Medicinal Chemistry(2002), vol. 37, pp. 21-30.
Fitzgerald et al., “Possible Role of Valvular Serotonin 5-HT2B Receptors in the Cardiopathy Associated with Fenfluramine,” Molecular Pharmacology (2000), vol. 57, pp. 75-81.
Glennon et al., “Influence of Amine Substituents of 5-HT2A Versus 5HT2C Binding of Phenylalkyl- and Indolylalkylamines,” J. Med. Chem. (1994), vol. 37, pp. 1929-1935.
Goodman, W. K., “Obsessive-Compulsive Disorder: Diagnosis and Treatment,” J. Clin. Psychiatry (1999), vol. 60 (Suppl. 18), pp. 27-32.
Jacob et al., “Structure-Activity Relationships of the Classic Hallucinogens and Their Analogs,” NIDA Research Monograph 146 (Hallucinogens, an Update), Eds. Lin, G.C. And Glennon, R.A. (1994), pp. 74-91.
Martin et al., “ 5-HT2C Receptor Agonists: Pharmacological Characteristics and Therapeutics Potential,” Journal of Pharmacology and Experimental Therapeutics, (1998), vol. 285, pp. 913-924.
Moreno et al., “Hallucinogen-Induced Relief of Obsessions and Compulsions,” Am. J. Psychiatry (1997), vol. 154. pp. 1037-1038.
Perrine, D. M. “Hallucinogens and Obsessive-Compulsive Disorder,” Am. J. Psychiatry (1999), vol. 156, pp. 1123.
Roth et al., “Insights into the Structure and Function of 5-HT2 Family Serotonin Receptors Reveal Novel Strategies for Therapeutic Target Development,” Expert Opin. Ther. Targets (2001), vol. 5(6), pp. 685-695.
Rothman, et al., “Evidence for Possible Involvement of 5-HT2B Receptors in the Cardiac Valvulopathy Associated with Fenfluramine and Other Serotonergic Medications,” Circulation (2000), vol. 102, pp. 2836-2841.
Smith et al., “Discovery and SAR of New benzazepines as potent and selective 5-HT2C Receptor Agonists for the Treatment of Obesity,” Bioorganic & Medicinal Chemistry Letters (2005), vol. 15. pp. 1467-1470.
Tecott et al., “Eating Disorder and Epilepsy in Mice lacking 5-HT2C Serotonin Receptors”, Nature (Apr. 6, 1995), vol. 374, pp. 542-546.
Ückert et al., “Current and Future Trends in the Oral Pharmacotherapy of Male Erectile Dysfunction,” Expert Opin. Investig. Drugs (2003), vol. 12(9), pp. 1521-1533.
Welmaker et al., “Synthesis and 5-Hydroxytryptamine (5-HT) Activity of 2,3,4,4a-Tetrahydro-1H-Pyrazinol[1,2-a] quinoxalin-5-(6H)ones and 2,3,4a,5,6-Hexahydro-1H-pyrazinol[1,2-a] quinoxalines,” Bioorganic & Medicinal Chemistry Letters (2000), vol. 10, pp. 1991-1994.
International Search Report and Written Opinion for International Application No. PCT/US05/34413 (11 pages), 2006.
Cecil Textbook of Medicine, 20th Edition (1996), vol. 2, pp. 2050-2057.
Cecil Textbook of Medicine, 20th Edition (1996), vol. 2, pp. 1992-1996.
FDA Mulls Drug to slow late-stage Alzheimer's [online], [retrieved on Sep. 23, 2003]. Retrieved from the internet, URL; http://www.cnn.com/2003/HEALTH/conditions/09/24/alzheimers.drug.ap/indexhtml>.
Autism[online], [retrieved on Dec. 5, 2006]. Retrieved from the internet, URL; http://en.wikipedia.org/wiki/autism>.
Whitaker-Azmitia, P., “Behavioral and Cellular Consequences of Increasing Serotonergic Activity During Brain Development: A Role in Autism?” Int. J. Devl. Neuroscience (2005), vol. 23, pp. 75-83.
Acral lick Dermatitis (Lick Granuloma)[online], [retrieved on Aug. 29, 2007], Retrieved from the internet, URL; http://www. animalhealthcare.com/handouts/dogs/acrall1.htm>.
Kumaran Govindaraj
Morency Cynthia
Roth Bryan
Sard Howard P.
Shuster Louis
Galenea Corp.
Lando & Anastasi LLP
Young Shawquia
LandOfFree
Indole compounds useful as serotonin selective agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indole compounds useful as serotonin selective agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole compounds useful as serotonin selective agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4259383